Edition:
United Kingdom

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

139.64SEK
2:16pm BST
Change (% chg)

-0.72kr (-0.51%)
Prev Close
140.36kr
Open
141.00kr
Day's High
143.00kr
Day's Low
138.40kr
Volume
72,406
Avg. Vol
158,120
52-wk High
143.40kr
52-wk Low
100.40kr

Chart for

About

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a... (more)

Overall

Beta: 0.78
Market Cap(Mil.): kr3,029.00
Shares Outstanding(Mil.): 21.71
Dividend: 0.74
Yield (%): 0.53

Financials

  VITR.ST Industry Sector
P/E (TTM): 55.24 39.42 32.59
EPS (TTM): 2.54 -- --
ROI: 21.64 14.34 12.60
ROE: 22.96 17.22 14.49

BRIEF-Vitrolife Q1 operating profit rises

* VITROLIFE AB Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION (EBITDA) AMOUNTED TO SEK 106 (95) MILLION Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

24 Apr 2018

BRIEF-Vitrolife hikes dividend, Q4 EBITDA up yr/yr

* Q4 ‍SALES AMOUNTED TO SEK 271 (251) MILLION, CORRESPONDING TO AN INCREASE OF 8 PERCENT IN SEK​

08 Feb 2018

BRIEF-Vitrolife says Embryoscope approved for sales in China

* SAYS ‍HAS TODAY RECEIVED MARKET APPROVAL FOR TIME-LAPSE INCUBATOR EMBRYOSCOPE IN CHINA​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)

01 Feb 2018

BRIEF-Vitrolife buys licensing rights for embryo transfer technology

* VITROLIFE ACQUIRES LICENSING RIGHTS TO TECHNOLOGY FOR EMBRYO TRANSFER

11 Jan 2018

Earnings vs. Estimates